Search Legislation

Advanced Search

The Health Protection (Coronavirus Restrictions) (No. 5) (Wales) Regulations 2020

Status:

Point in time view as at 28/01/2022.

Changes to legislation:

There are currently no known outstanding effects for the The Health Protection (Coronavirus Restrictions) (No. 5) (Wales) Regulations 2020, PART 3. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

PART 3E+WRequirement to isolate etc.

CHAPTER 1E+WRequirement to isolate etc. where person tests positive for coronavirus or has close contact with such person

Interpretation of PartE+W

5.—(1) In this Part, “close contact” means contact that a contact tracer considers may lead to a risk of infection or contamination with coronavirus, including—

(a)having face-to-face contact with a person at a distance of less than 1 metre;

(b)spending more than 15 minutes within 2 metres of a person;

(c)travelling in a car or other small vehicle with a person or in close proximity to a person on an aeroplane or in the same carriage of a train.

F1(1A) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(2) In [F2regulation 6], references to an “adult” (“A”) include references to a child aged 16 or 17.

(3) For the purposes of this Part, a person has responsibility for a child if the person has—

(a)custody or charge of the child for the time being, or

(b)parental responsibility for the child.

(4) For the purposes of these Regulations, notification by means of the NHS Covid 19 smartphone app developed and operated by the Secretary of State is not a notification.

[F3(5) For the purposes of regulations 6 and 7, “a contact tracer” includes—

(a)Public Health Wales National Health Service Trust;

(b)the Secretary of State.]

Textual Amendments

Commencement Information

I1Reg. 5 in force at 20.12.2020, see reg. 1(3)

Requirement to isolate: adult with coronavirusE+W

6.—(1) This regulation applies where an adult (“A”) is notified by a contact tracer that A has tested positive for coronavirus.

(2) A may not leave or be outside the place where A is living before the end of the last day of A's isolation unless regulation 10 or 11 applies.

(3) If requested by a contact tracer, A must notify the contact tracer—

(a)of the name of each person living at the place A is living, and

(b)of the address of that place.

(4) The last day of A's isolation is the last day of the period of [F45 days] beginning with the day after the day of the test which led to the notification referred to in paragraph (1) being given.

(5) But where A reports to a contact tracer the day on which symptoms first developed, the last day of A's isolation is the last day of the period of [F55 days] beginning with the day after the day which A reports as being the day on which the symptoms first developed.

Textual Amendments

Modifications etc. (not altering text)

Commencement Information

I2Reg. 6 in force at 20.12.2020, see reg. 1(3)

Requirement to isolate: child with coronavirusE+W

7.—(1) This regulation applies where an adult (“A”) is notified by a contact tracer that a child (“C”) for whom A is a responsible adult has tested positive for coronavirus.

(2) C may not leave or be outside the place where C is living before the end of the last day of C's isolation unless regulation 10 or 11 applies.

(3) If requested by a contact tracer, A must notify the contact tracer—

(a)of the name of each person living at the place where C is living, and

(b)of the address of that place.

(4) The last day of C's isolation is the last day of the period of [F65 days] beginning with the day after the day of the test which led to the notification referred to in paragraph (1) being given.

(5) But in a case where A reports to a contact tracer the day on which C's symptoms first developed, the last day of C's isolation is the last day of the period of [F75 days] beginning with the day after the day which A reports as being the day on which C's symptoms first developed.

Textual Amendments

Modifications etc. (not altering text)

Commencement Information

I3Reg. 7 in force at 20.12.2020, see reg. 1(3)

Requirement to isolate after close contact: adultE+W

8.—(1) This regulation applies where an adult (“A”) is notified by a contact tracer that A has had close contact with a person (“P”) who has tested positive for coronavirus.

(2) A may not leave or be outside the place where A is living before the end of the last day of A's isolation unless regulation 10 or 11 applies.

(3) If requested by a contact tracer, A must notify the contact tracer of the address of the place where A is living.

(4) The last day of A's isolation is the last day of the period of 10 days beginning with the day after the day which a contact tracer records as being the last day on which A had close contact with P before A received the notification referred to in paragraph (1).

(5) But where A is living in the same place as P, the last day of A's isolation is—

(a)where P, or, where P is a child, a responsible adult (“R”) on P's behalf, reports to a contact tracer the day on which P's symptoms first developed, the last day of the period of 10 days beginning with the day after the day on which P, or R, reports as being the day on which P's symptoms first developed;

(b)where no symptoms are reported, the last day of the period of 10 days beginning with the day after the day of the test which led to the notification being given to P, or R, that P had tested positive for coronavirus.

Commencement Information

I4Reg. 8 in force at 20.12.2020, see reg. 1(3)

Requirement to isolate after close contact: childE+W

F89.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Requirement to isolate after close contact with person with Omicron variant: childE+W

F99A.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Isolation requirements: general exceptionsE+W

10.—(1) Paragraph (2) applies where a person is required to not leave or be outside of the place where the person is living by virtue of regulation 6(2), 7(2) [F10or 8(2)].

(2) The person may leave and be outside the place where the person is living for as long as is necessary—

(a)to seek medical assistance, where this is required urgently or on the advice of a registered medical practitioner;

(b)to access veterinary services where—

(i)they are urgently required, and

(ii)it is not possible for another person at the place that the person is living to access those services;

(c)to fulfil a legal obligation, including attending court or satisfying bail conditions, or to participate in legal proceedings, where it is not possible or practicable to do so without leaving the place where the person is living;

(d)to avoid illness, injury or other risk of harm;

[F11(da)to enable the person to seek to prevent illness, injury or other risk of harm to another person (“A”) where—

(i)it is not possible or not practicable for somebody else to assist A,

(ii)the person is not assisting A as part of the person’s work or through providing voluntary services, and

(iii)the risk of harm to A from being in the same place as the person is less than the risk of harm to A that the person is seeking to prevent;]

(e)for compassionate reasons, including to attend the funeral of—

(i)a family member;

(ii)a close friend;

(f)to obtain basic necessities (including for other persons at the place where the person is living or any pets at that place) where it is not possible or practicable—

(i)for another person at the place where the person is living to obtain them, or

(ii)to obtain them by delivery to that place from a third party;

(g)to access public services (including social services or victims' services) where—

(i)access to the service is critical to the person's well-being, and

(ii)the service cannot be provided if the person remains at the place where the person is living;

[F12(h)to move to a different place to live—

(i)where it becomes impracticable to remain at the place where the person is living, or

(ii)to prevent illness to another person who lives in the place where the person is living;]

(i)where the person is a child who does not live in the same household as the child's parents, or one of the child's parents, to continue existing arrangements for access to, and contact between, the child and the child's parents, and for the purposes of this sub-paragraph, “parent” includes a person who is not a parent of the child, but who has parental responsibility for, or who has care of, the child.

(3) Regulations 6(2), 7(2) [F13and 8(2)] do not apply to a person who is homeless.

(4) Regulation 6(2) does not apply to a person who—

(a)has tested positive for coronavirus in the course of a research study (the “prior test”), and

(b)tests positive for coronavirus in the course of the same study within the period of 90 days beginning with the date of the prior test.

[F14(5) Regulation 8(2) does not apply to a person who—

(a)has completed a course of doses of an authorised vaccine, and—

(i)that course of doses was administered to the person in the United Kingdom,

(ii)the day on which the person had the close contact which resulted in the notification described in regulation 8(1) is more than 14 days after the day on which the person completed that course of doses, and

(b)if requested to do so by the contact tracer who gave the notification described in regulation 8(1), provides evidence that they have completed the course of doses of an authorised vaccine in accordance with sub-paragraph (a).

(6) Regulation 8(2) does not apply to a person who—

(a)has participated in, or is participating in, a clinical trial of a vaccine for vaccination against coronavirus carried out in the United Kingdom in accordance with the requirements of the Medicines for Human Use (Clinical Trials) Regulations 2004, and

(b)if requested to do so by the contact tracer who gave the notification described in regulation 8(1), provides evidence that they have participated in, or are participating in, a clinical trial in accordance with sub-paragraph (a).

F15(6ZA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

[F16(6A) A contact tracer may, for the purposes of determining whether to request evidence from a person in accordance with paragraph (5)(b) or (6)(b), obtain and use information about whether a person—

(a)has completed a course of doses of an authorised vaccine;

(b)has participated in, or is participating in, a clinical trial of a vaccine for vaccination against coronavirus carried out in the United Kingdom in accordance with the requirements of the Medicines for Human Use (Clinical Trials) Regulations 2004.]

(7) For the purposes of paragraph (5), a person has completed a course of doses if that person has received the complete course of doses specified—

(a)in the summary of product characteristics approved as part of the marketing authorisation for the authorised vaccine, or

(b)in the instructions for usage approved as part of the authorisation by the licensing authority on a temporary basis under regulation 174 of the Human Medicines Regulations 2012 for the authorised vaccine.

(8) In this regulation—

(a)“authorised vaccine” means a medicinal product—

(i)authorised for supply in the United Kingdom in accordance with a marketing authorisation, or

(ii)authorised by the licensing authority on a temporary basis under regulation 174 of the Human Medicines Regulations 2012,

for vaccination against coronavirus;

(b)“clinical trial” has the meaning given in regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004;

(c)“the licensing authority” has the meaning given in regulation 6(2) of the Human Medicines Regulations 2012;

(d)“marketing authorisation” has the meaning given in regulation 8(1) of the Human Medicines Regulations 2012;

(e)“medicinal product” has the meaning given in regulation 2 of the Human Medicines Regulations 2012.]

Textual Amendments

Commencement Information

I5Reg. 10 in force at 20.12.2020, see reg. 1(3)

Transitional provision: isolation requirementsE+W

F1710A.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Transitional provision: isolation requirementsE+W

F1810B.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

[F19Transitional provision: isolation requirementsE+W

10C.—(1) Where an adult is required to not leave or be outside of the place where the adult is living in accordance with regulation 6(2) immediately before the Health Protection (Coronavirus Restrictions) (No. 5) (Wales) (Amendment) (No. 3) Regulations 2022 come into force, the last day of the adult’s isolation is to be determined in accordance with regulation 6(4) or (5) as amended by those Regulations.

(2) Where a child is required to not leave or be outside of the place where the child is living in accordance with regulation 7(2) immediately before the Health Protection (Coronavirus Restrictions) (No. 5) (Wales) (Amendment) (No. 3) Regulations 2022 come into force, the last day of the child’s isolation is to be determined in accordance with regulation 7(4) or (5) as amended by those Regulations.]

Textual Amendments

Isolation requirements: exception for participants in a testing schemeE+W

11.—(1) This regulation applies where—

(a)a person (“P”) is required to not leave or be outside of the place where P is living by virtue of regulation 8(2) F20... (“the isolation requirement”), and

(b)P agrees to participate in a testing scheme.

F21(1A) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(2) If P's first test under the testing scheme is negative for coronavirus, the isolation requirement ceases to apply to P from the time P receives the result of the test, subject to paragraphs (3) and (4).

(3) If the result of a test taken by P under the testing scheme is positive for coronavirus, the isolation requirement applies to P from the time P receives the result of the test as if it had not ceased to apply by virtue of paragraph (2).

(4) Despite paragraph (2) the isolation requirement applies to P on—

(a)non-test days;

(b)any day on which P is required to take a test under the scheme but fails to do so.

(5) If P's last test under the testing scheme is negative for coronavirus, the isolation requirement ceases to apply to P from the earlier of—

(a)the time P receives the result of the test, or

(b)P's last day of isolation calculated in accordance with regulation 8 F22....

F23(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(7) In this regulation—

(a)“testing scheme” means a scheme designated by the Welsh Ministers under which P is required to take a number of tests for coronavirus specified in the scheme, on dates and in a manner so specified;

(b)“non-test day” means a day between the day on which P takes the first and last test under the scheme on which P is not required to take a test under the scheme.

Textual Amendments

Commencement Information

I6Reg. 11 in force at 20.12.2020, see reg. 1(3)

Requirement to isolate: specific provision for people who are in Wales on 22 January 2021 and who have been in the Democratic Republic of the Congo or the United Republic of Tanzania in the previous 10 daysE+W

F2411A.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Requirement to isolate: specific provision for people who are in Wales on 29 January 2021 and who have been in certain countries in the previous 10 daysE+W

F2511AA.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Isolation requirements: specific exception for people who have been in certain countriesE+W

F2611B.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

Requirement on persons with responsibility for childrenE+W

12.  Where a requirement is imposed under regulation 7(2) F27... F28... on a child, a person with responsibility for the child must take all reasonable measures to ensure that the child complies with the requirement.

Textual Amendments

Commencement Information

I7Reg. 12 in force at 20.12.2020, see reg. 1(3)

Withdrawing a notice which requires isolationE+W

13.—(1) This regulation applies where a contact tracer—

(a)has given a notification under regulation 6(1), 7(1), [F29or 8(1)] (“the original notification”), but

(b)subsequently notifies the recipient of the original notification that it is withdrawn.

(2) The original notification is treated as if it had not been given.

Textual Amendments

Commencement Information

I8Reg. 13 in force at 20.12.2020, see reg. 1(3)

Withdrawing a notification that close contact was with person with Omicron variantE+W

F3013A.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

CHAPTER 2E+WInformation

Power to use and disclose informationE+W

14.—(1) A contact tracer may disclose only such relevant information to a person (“the information holder”) as is necessary for the information holder to have—

(a)for the purposes of—

(i)carrying out a function under these Regulations,

(ii)preventing danger to the health of the public as a result of the spread of infection or contamination with coronavirus, or

(iii)monitoring the spread of infection or contamination with coronavirus, or

(b)for a purpose connected with, or otherwise incidental to, a purpose described in sub-paragraph (a).

(2) Relevant information is—

(a)where a person is required to isolate in accordance with regulation 6(2), 7(2) [F31or 8(2)]—

(i)the person's contact information and date of birth, or, where the person is a child, the contact details of the adult who is notified that the child is required to isolate and the child's date of birth;

(ii)the date the notification was given under regulation 6(1), 7(1) [F32or 8(1)];

(iii)the particular period in respect of which the person is required to not leave or be outside of the place where the person is living calculated in accordance with regulation 6, 7 [F33or 8];

F34(aa). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

[F35(ab)information about whether a person—

(i)has completed a course of doses of an authorised vaccine;

(ii)has participated in, or is participating in, a clinical trial of a vaccine for vaccination against coronavirus carried out in the United Kingdom in accordance with the requirements of the Medicines for Human Use (Clinical Trials) Regulations 2004;]

(b)confirmation a person did not receive a positive coronavirus test and the person's name, contact information and date of birth, or, where the person is a child, the name and contact details of an adult with responsibility for the child in addition to the child's name and date of birth.

(3) The information holder may use relevant information disclosed under paragraph (1) only to the extent that it is necessary—

(a)for the purposes of—

(i)carrying out a function under these Regulations,

(ii)preventing danger to the health of the public as a result of the spread of infection or contamination with coronavirus, or

(iii)monitoring the spread of infection or contamination with coronavirus, or

(b)for a purpose connected with, or otherwise incidental to, a purpose described in sub-paragraph (a).

(4) Subject to paragraph (6), the information holder may disclose only such relevant information to another person (the “recipient”) as is necessary for the recipient to have—

(a)for the purposes of—

(i)carrying out a function of the recipient under these Regulations,

(ii)preventing danger to the health of the public as a result of the spread of infection or contamination with coronavirus, or

(iii)monitoring the spread of infection or contamination with coronavirus, or

(b)for a purpose connected with, or otherwise incidental to, a purpose described in sub-paragraph (a).

(5) Subject to paragraph (7), disclosure which is authorised by this regulation does not breach—

(a)an obligation of confidence owed by the person making the disclosure, or

(b)any other restriction on the disclosure of information (however imposed).

(6) This regulation does not limit the circumstances in which information may otherwise be disclosed under any other enactment or rule of law.

(7) Nothing in this regulation authorises the use or disclosure of personal data where doing so contravenes the data protection legislation.

[F36(8) In this regulation—

(a)“authorised vaccine” and “clinical trial” have the same meanings as in regulation 10;

(b)“data protection legislation” and “personal data” have the same meanings as in section 3 of the Data Protection Act 2018.]

Textual Amendments

Commencement Information

I9Reg. 14 in force at 20.12.2020, see reg. 1(3)

Back to top

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open the Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area. The revised version is currently only available in English.

Original (As Enacted or Made) - English: The original English language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Original (As Enacted or Made) - Welsh:The original Welsh language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search. A point in time version is only available in English.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources

The data on this page is available in the alternative data formats listed: